In vivo proliferation of tumoral cells was assessed by immunodetection of the proliferation biomarker Ki-67, which is expressed in cycling cells and identifies the proliferating fraction in a given cell population (36), and by detection of tumor cells that incorporate EdU into nascent DNA. The gene discussed is MKI67; the disease is neoplasm.